The Board of Directors consists of elected members of the Society. Meeting at least once annually, it is entrusted with the corporate governance and overall management of the ISBT. The Board sets the strategic direction of the Society. Its general and financial responsibilities are detailed in the Statutes. All permanent and ad hoc ISBT committees and working parties are appointed by the Board. The Board determines when and where international and regional congresses are to be held. The ISBT Board delegates specific management and administrative functions to the Executive Committee, who are all members of the Board. This committee in turn, works to ensure that the Society acts in accordance with Board decisions and with resolutions of the General Assembly.
The ISBT Board of Directors is composed of the members of the Executive Committee, together with nine Regional Directors. The Statutes designate that the Executive Committee is composed of the President, President Elect, Past President, Vice Presidents, Secretary General and the Treasurer.
Martin L. Olsson received his M.D. (1991) and Ph.D. (1997) from Lund University in Sweden where he is a full Professor of Transfusion Medicine since 2006 and also the Deputy Head of a large research department. He is also the Medical Director of the Nordic Blood Group Reference Laboratory in Lund. He was a Visiting Scientist at IBGRL/BITS in Bristol, UK (1996) and a Visiting Associate Professor/Lecturer at Harvard Medical School (2003-2008). His main clinical and research interest involves the biochemistry, genetics and function of red cell surface molecules with a special emphasis on glycan blood groups and their role in host-pathogen interactions. He has received 12 awards from different organisations including ISBT, BBTS and AABB. He previously served on the Board of ISBT (2006-2008), as ISBT’s first Scientific Secretary (2011-2015).
Erica Wood is vice-president of ISBT, and a member of its working parties on clinical practice, haemovigilance, and transfusion-transmitted infectious diseases. From 2010-2014 she was ISBT regional director for the Western Pacific region. Erica is head of the Transfusion Research Unit in the Department of Epidemiology and Preventive Medicine at Monash University in Melbourne, Australia. She is a consultant haematologist at Monash Health and holds an honorary appointment at the Peter MacCallum Cancer Centre. Erica is president of the International Haemovigilance Network, past-president of the Australian and New Zealand Society of Blood Transfusion, and a member of the World Health Organization Expert Advisory Panel in Transfusion Medicine. Erica has served as Chief Examiner (Haematology) for the Royal College of Pathologists of Australasia and chair of the Joint Specialist Advisory Committee in Haematology. She is a member of the Victorian Blood Matters program advisory committee and the expert group of its Serious Transfusion Incident Reporting (STIR) haemovigilance program. In 2013, Erica was awarded a Churchill Fellowship to support her practice and research in patient blood management.
So-Yong is currently the Director of the Jungbu Blood Laboratory Center of the Korean Red Cross (KRC). She has been the Director of the Safety Bureau at the KRC Blood Services Headquarters, Director of the Blood Transfusion Research Institute, and Director of the Seoul Nambu Blood Center. As the current Director for Scientific Affairs of the Korean Society of Blood Transfusion (KSBT), she is responsible for organizing the scientific program of the KSBT annual meetings and for promoting educational and research activities among KSBT members.
Since 2006 she has been an active representative of the Asia Pacific Blood Network (APBN) and served as the Vice Chair of the APBN from 2015-2016.
Masja de Haas (MD, PhD) is vice-president of Sanquin Diagnostic Services (Amsterdam) and professor in Immunohaematology (University of Leiden), in the Netherlands. She has now over 20 years of experience in transfusion medicine. Her research interests are auto-and alloimmune-mediated blood cell destruction. This extends to the evaluation and design of optimal diagnostic and treatment strategies, such as transfusion policies. She is a member of the ISBT Working Parties for Red Cell Immunogenetics and Blood Group Terminology and Rare donors, respectively. She aims to contribute to the ISBT community by supporting the dissemination of knowledge to strengthen transfusion medicine worldwide.
Ravi Reddy is currently the Chief Operations Officer of South African National Blood Service (SANBS) and has worked for the Blood Transfusion Services in South Africa for 30 years. His responsibilities are to direct all aspects related to the Collection, Processing, Testing and Issue of approximately 823 000 units of blood in SANBS as well as developing and implementing strategic initiatives to improve blood supply and safety.
He is a member of the WHO expert committee on Blood Safety and biological standards and is also a non-executive Board member of the African Society for Blood Transfusion (AfSBT). Ravi was President of ISBT from 2016 to 2018.
Gwen Clarke is a physician with training at the University of Alberta and at Emory University. She has clinical and research interests in perinatal immunohematology and experience as a hospital transfusion medicine physician and with the Canadian blood supplier. Her current role with Canadian Blood services includes medical leadership for perinatal and immunohematology reference laboratories, consultation in donor testing and for the Rare Blood Program. Gwen is a Clinical Professor in the Department of Laboratory Medicine at the University of Alberta. She is a former program director for residency training in Hematopathology and an examiner for the Royal College of Physicians and Surgeons of Canada. Gwen has recently completed a term as president of the Canadian Society for Transfusion Medicine.
Eric Jansen is currently working as an independent consultant in Blood Supply Chain Management. He is partner together with prof. dr. ir. Jan van der Wal in the company Blood Supply Chain Solutions. Eric retired in 2013 from his role as managing director of the Sanquin Blood Service Amsterdam in the Netherlands. Together with Steve Morgan he started and chaired the EBA Benchmarking project, aiming at performance improvement. Best practice are identified and via the EBA Flying Squad members in Europe (and US) were helped in the implementation of these best practices. Eric Jansen also worked in University and general hospitals in the Netherlands.
Nine Regional Directors are elected to represent the WHO regions. strategic direction of the Society and provide guidance on relevant issues, they promote the Society and the ISBT Academy and they act as a link between the ISBT and National and Regional Societies.
More information about the new Regional Directors (2018-2022) will follow soon.
Justina Kordai Ansah is the CEO of the National Blood Service Ghana and a Consultant Physician in Transfusion Medicine. She is a Fellow of the Ghana College of Physicians and Surgeons (GCPS), and Chair, trainer and chief examiner of the Faculty of Laboratory Medicine of the College. She is a board member of the African Society for Blood Transfusion (AfSBT). She is also a member of the WHO expert advisory committee on Blood Safety and executed consultancy missions for both WHO HQ and AFRO Region. Justina is the chair of the ISBT Working Party on Blood Supply Management, a member of ISBT Working Party on Donors and Donation, and a member of the ISBT standing committee on ethics. She has a number of publications to her credit and has contributed to a number of documents on blood safety for WHO and other organizations.
Mindy Goldman is the medical director, donor and clinical services at Canadian Blood Services in Ottawa, Ontario. Mindy completed her medical degree at the University of Montreal, and did subsequent training in internal medicine at McGill University in Montreal and hematology and transfusion medicine at McMaster University in Hamilton, Ontario. Mindy is responsible for donor criteria and policies and her current interests include donor health and safety, deferral policies for high risk donor behaviours, and bacterial contamination of blood components. She has been a member of the ISBT Academy and the Rare Donor Working Party and is currently a member of the Haemovigilance Working Party.
Lilian Castilho obtained her Master and PhD degrees at Federal University of São Paulo in Brazil and performed post-doctoral studies in molecular immunohematology at the New York Blood Center, USA. She has worked in laboratories in Brazil and served as consultant for the American Red Cross in Philadelphia, USA. Lilian has experience in the area of immunology, with emphasis on immunohematology and genetics of blood groups. Currently she is a Professor at University of Campinas in Brazil, where she teaches and has an active research laboratory that supports both projects being carried out by graduate and post graduate students and collaborative research projects. She has served on numerous committees and has been the vice-chair of the ISBT working party on Red Cell Immunogenetics and Blood Group terminology.
Birgit Gathof is director of the Transfusion Medicine Unit of the University Hospital of Cologne, Germany. Experience of nine years internal medicine and over 20 years in blood transfusion. Birgit is active in the ISBT Working Party “Clinical transfusion” and co-chair of its subgroup responsible for Patient Blood Management (PBM) educational material. She is also chair of the WP “Hämotherapie” of the German DGTI. Active in the promotion of PBM in the setting of long standing quality assurance in hemotherapy by teaching and the respective explanation and revision of relevant guidelines. Her scientific interests include different aspects of hemotherapy with respect to donor and recipient and product safety and development (pathogenreduction).
Shubha Allard MD FRCP FRCPath, Consultant Haematologist, Barts Health NHS Trust and NHS Blood and Transplant, UK. Actively promoting Patient Blood Management with safe and appropriate use of blood and components at local, regional and national level. Lead Consultant Transfusion supervising the clinical and laboratory transfusion service across merged Barts Health NHS Trust comprising five hospitals. Clinical Tutor, NHSBT. Actively involved in education at undergraduate and postgraduate level. Vice chair of the British Society for Haematology Guidelines Committee developing national guidelines. Joint Chair ISBT Clinical Transfusion Working Party.
May Raouf is an haematopathologist with 28 years of experience in clinical and academic aspects of transfusion medicine. She is currently serving as director of the Dubai Blood Donation Centre and coordinator for Emirates Supreme National Blood Transfusion Committee. She is a member of the WHO expert panel for transfusion safety and has served as chairman for the local organizing committee of ISBT's 34th International congress in Dubai. May is also chairing the blood transfusion program in the MedLab Annual Congresses in Dubai and has organized many international scientific meetings with WHO. She has served as medical director and quality manager for internationaly recognized blood banks.
Since February 2015, Yuyun Soedarmono is staff of the Directorate of Primary Health Services, responsible for drafting and formulating the Government Regulation on Blood Services. From 2004-2015 she worked as a director of the Central Blood Transfusion Services of the Indonesian Red Cross (IRC) that is responsible for guiding, monitoring and evaluating the 211 IRC Blood Canters. As of 1994 she is involved in training and education about the blood service for the doctors, laboratory technicians and nurses, and also students of the Master Program of Transfusion Science – Faculty of Medicine – Indonesian University, and in 2010 started working as the Manager of this program. Since 2015, she is the President of the Indonesian Association of Transfusion Medicine (IATM). She is also affiliated to the WHO.
Lin Fung is the Associate Professor in Medical Laboratory Science at the University of the Sunshine Coast. She has worked in tertiary hospital pathology laboratories, led research teams at the Australian Blood Service and University of Queensland, and was the Chair of the ISBT Granulocyte Immunobiology Working Party. She serves on two hospital blood management committees and has an active interest in translational transfusion research. This led her to set up the OptiBlood research team, which runs studies directed at optimising the patient’s blood and use of blood products. Lin enjoys public speaking, facilitating collaborations, mentoring young scientists and is an advocate for evidence based transfusion practice.
Veera Nadarajan currently holds the positions of Associate Professor at the Department of Pathology, University of Malaya as well as the Head of the Department of Transfusion Medicine at the University Malaya Medical Centre. He has more than 20 years of experience, with diverse research interests that include blood group serology, blood donor care and molecular hematology. He is also actively involved in teaching and training doctors on a national level. Veera sits on several national committees with regards to curriculum developments, specialist accrediation and quality standarts and is also a member of the ISBT Academy.